AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Oct 6, 2011
30016_dirs_2011-10-06_e8d10c6e-ae15-4170-843d-c590a582cd94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-10-04
Reporting Person: AYERS JONATHAN W (Director, CHAIRMAN, PRESIDENT & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-04 | Common Stock | M | 20000 | $12.6 | Acquired | 317697 | Direct |
| 2011-10-04 | Common Stock | S | 9500 | $64.2054 | Disposed | 308197 | Direct |
| 2011-10-04 | Common Stock | S | 5500 | $64.5939 | Disposed | 302697 | Direct |
| 2011-10-05 | Common Stock | M | 20000 | $12.6 | Acquired | 322697 | Direct |
| 2011-10-05 | Common Stock | S | 14597 | $66.1209 | Disposed | 308100 | Direct |
| 2011-10-05 | Common Stock | S | 403 | $66.7387 | Disposed | 307697 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-04 | Non-Qualified Stock Option (right to buy) | $12.60 | M | 20000 | Disposed | 2012-01-28 | Common Stock (20000) | Direct |
| 2011-10-05 | Non-Qualified Stock Option (right to buy) | $12.6 | M | 20000 | Disposed | 2012-01-28 | Common Stock (20000) | Direct |
Footnotes
F1: Includes 79 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2011.
F2: The reported sale above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/03/2011.
F3: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $63.88 to $64.85, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3, 4, 5 and 6 to this Form 4.
F4: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $65.00 to $65.43, inclusive.
F5: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $65.66 to $66.57, inclusive.
F6: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $66.69 to $66.75, inclusive.
F7: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (01/28/2003) of the date of grant.